RESUMEN
Neonatal exposure to high-dose 17ß-estradiol (E2) affects the morphology and physiology of sex and accessory sex organs in the long term. In this study, we examined the effects of E2 imprinting on male sexual behavior, fertility, and the number of androgen receptor (AR)-expressing cells in the hypothalamus. E2-treated males showed copulatory behavior represented by mounts and/or intromissions, demonstrating the preservation of aspects of male behavior. They had slightly increased latency for first intromission and a reduced number of ejaculations, associated with a 50% reduction in the fertility index. AR expression in the hypothalamus was assessed by RT-PCR, western blotting, and immunohistochemistry. Treated rats had a significantly lower ventral prostate (VP) weight, demonstrating the efficacy of the treatment. The AR mRNA and protein content in the hypothalamus of E2-treated animals was reduced to the levels of females. AR-expressing cell counts in the ventromedial, anterior medial preoptic, paraventricular nuclei, and preoptic areas were different from control males, and similar to those of females. In conclusion, E2 imprinting resulted not only in ill-developed sexual organs, but also affected sexual behavior, resulting in a female-type hypothalamus, at least with respect to the abundance of AR mRNA and protein and the number of AR-expressing cells in important regions/tracts.
Asunto(s)
Estrógenos/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Hipotálamo/citología , Receptores Androgénicos/metabolismo , Conducta Sexual Animal/efectos de los fármacos , Maduración Sexual/efectos de los fármacos , Animales , Femenino , Masculino , Ratas , Receptores Androgénicos/genéticaRESUMEN
1. Orchidectomy results in long-term testosterone deprivation similar to that observed in male clinical pathologies, such as hypogonadism and age-related reductions in plasma testosterone concentrations. Although the vascular effects of these sorts of hormone deprivations are known in arteries, they have not been studied to the same extent in veins. 2. The aim of the present study was to determine the effect of orchidectomy, with or without subsequent testosterone replacement (started 23 days after orchidectomy; 10 mg/kg, i.m., testosterone propionate once every 5 days for 3 weeks), on responses of rat isolated portal veins and vena cavae to exogenous phenylephrine (PE). Isolated vessels were mounted in an organ bath and concentration-response curves constructed to PE (10(-10)-10(-4) mol/L), endothelin (ET; 10(-10)-10(-5) mol/L) and KCl (10(-2)-1.2 x 10(-1) mol/L; as a control). 3. Orchidectomy had no effect on contractile responses of either the portal vein or vena cava to KCl. However, orchidectomy enhanced the maximum response (R(max)) of the portal vein, but not the vena cava, to PE. Testosterone replacement had no effect on these responses. The effects of orchidectomy on the R(max) to PE in portal veins were not altered by the nitric oxide synthase inhibitor N(G)-nitro-l-arginine methyl ester (10(-4) mol/L) alone or combined with 10(-5) mol/L indomethacin (a non-selective cyclo-oxygenase inhibitor), but they were abolished following treatment of isolated vessels with the ET(A) and ET(B) receptor antagonists BQ-123 and BQ-788 (both at 10(-6) mol/L). Orchidectomy did not alter portal vein responses to the application of exogenous ET. 4. The results of the present study indicate that orchidectomy-induced decreases in plasma testosterone can increase the venoconstrictor effects of PE on the portal vein and that this effect involves activation of both ET(A) and ET(B) receptors by locally produced ET.
Asunto(s)
Orquiectomía , Fenilefrina/farmacología , Vena Porta/efectos de los fármacos , Vena Porta/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Técnicas In Vitro , Masculino , Ratas , Ratas Wistar , Testosterona/sangre , Vasoconstricción/efectos de los fármacos , Vasoconstricción/fisiologíaRESUMEN
Sibutramine is an inhibitor of norepinephrine and 5-HT reuptake largely used in the management of obesity. Although a fairly safe drug, postmarketing adverse effects of sibutramine were reported including abnormal ejaculation in men. This study investigates the effects of sibutramine on ejaculation and vas deferens and seminal vesicle contractility. Adult male rats received sibutramine (5; 20; or 50 mg kg(-1), ip) and after 60 min were exposed to receptive females for determination of ejaculation parameters. The vasa deferentia and seminal vesicles of untreated rats were mounted in isolated organ baths for recording of isometric contractions and HEK293 cells loaded with fluorescent calcium indicator were used to measure intracellular Ca(2+) transients. Sibutramine 5 and 20 mg kg(-1) reduced ejaculation latency whereas 50 mg kg(-1) increased ejaculation latency. Sibutramine 3 to 30 microM greatly increased the sensitivity of the seminal vesicle and vas deferens to norepinephrine, but at concentrations higher than 10 microM there were striking depressions of maximal contractions induced by norepinephrine, carbachol and CaCl(2). In HEK293 cells, sibutramine 10 to 100 microM inhibited intracellular Ca(2+) transients induced by carbachol. Depending on the doses, sibutramine either facilitates or inhibits ejaculation. Apart from its actions in the central nervous system, facilitation of ejaculation may result from augmented sensitivity of smooth muscles to norepinephrine while reductions of intracellular Ca(2+) may be involved in the delayed ejaculation observed with high doses of sibutramine.
Asunto(s)
Depresores del Apetito/efectos adversos , Ciclobutanos/efectos adversos , Eyaculación/efectos de los fármacos , Contracción Isométrica/efectos de los fármacos , Vesículas Seminales/efectos de los fármacos , Conducto Deferente/efectos de los fármacos , Agonistas de Receptores Adrenérgicos alfa 1 , Animales , Calcio/metabolismo , Cloruro de Calcio/farmacología , Carbacol/farmacología , Línea Celular , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Técnicas In Vitro , Masculino , Neurotransmisores/farmacología , Norepinefrina/farmacología , Ratas , Ratas Wistar , Receptores Muscarínicos/metabolismo , Vesículas Seminales/metabolismo , Conducto Deferente/metabolismoRESUMEN
The present study investigated the long-term effects of prenatal betamethasone exposure on sperm quality and count, fertility and plasma testosterone levels in adult male rats. Pregnant rats received 0.1 mg kg(-1) betamethasone on Days 12, 13, 18 and 19 of pregnancy. This treatment impaired sperm quality, sperm production, fertility and plasma testosterone levels in adult male offspring compared to the control group. Thus, the results of the present study indicate that the long-term effects of prenatal betamethasone exposure may be deleterious to offspring. The consequent decrease in testosterone production during adulthood, in association with damaged semen parameters, may explain for the observed decrease in the capacity of adult male offspring to themselves generate viable descendants.
Asunto(s)
Betametasona/toxicidad , Fertilidad/fisiología , Glucocorticoides/toxicidad , Efectos Tardíos de la Exposición Prenatal/sangre , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Semen/fisiología , Testosterona/sangre , Animales , Betametasona/farmacología , Femenino , Fertilidad/efectos de los fármacos , Glucocorticoides/farmacología , Infertilidad Masculina/inducido químicamente , Masculino , Modelos Animales , Embarazo , Efectos Tardíos de la Exposición Prenatal/patología , Ratas , Ratas Wistar , Semen/citología , Semen/efectos de los fármacos , Recuento de Espermatozoides , Espermatozoides/citología , Espermatozoides/efectos de los fármacos , Espermatozoides/fisiologíaRESUMEN
The present study examined the effects of letrozole exposure during brain sexual differentiation on endocrine, behavioural and neurochemical parameters in male rat descendants. Pregnant female rats received 1 mg kg(-1) day(-1) letrozole or vehicle by oral gavage on gestational Days 21 and 22. Exposure to letrozole reduced anogenital distance in males on postnatal Day (PND) 22. At adulthood (PND 75), plasma testosterone levels and hypothalamic dopaminergic activity were increased, but sexual competence was impaired, because fewer successful sexual behaviours (mount, intromission and principally ejaculation) were observed. The impairment of reproductive function by prenatal exposure to an aromatase inhibitor reinforces the importance of adequate oestrogenic activity during perinatal sexual differentiation for complete masculinisation of the hypothalamus.
Asunto(s)
Inhibidores de la Aromatasa/farmacología , Química Encefálica/efectos de los fármacos , Sistema Endocrino/efectos de los fármacos , Exposición Materna , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Conducta Sexual Animal/efectos de los fármacos , Animales , Monoaminas Biogénicas/análisis , Peso Corporal/efectos de los fármacos , Sistema Endocrino/fisiología , Femenino , Letrozol , Masculino , Exposición Materna/efectos adversos , Nitrilos/farmacología , Embarazo , Efectos Tardíos de la Exposición Prenatal/sangre , Ratas , Ratas Wistar , Conducta Sexual Animal/fisiología , Testosterona/sangre , Triazoles/farmacologíaRESUMEN
The aim of this study was to investigate the potential estrogenic activity of fenvalerate by examining reproductive and fertility capabilities in Wistar rats. Adult male animals were treated for 30 d with 20 or 40 mg/kg/d fenvalerate or corn oil (vehicle) by oral gavage. Further, a possible estrogenic activity of fenvalerate (0.4, 1, 4, 8, or 40 mg/kg) was tested after a 3-d treatment of immature female rats using the uterotrophic assay. Exposure to the higher dose of fenvalerate was toxic to testis and epididymis as shown by a decrease in the absolute weights and sperm counts in both organs. Although the sperm counts were reduced, the fertility and sexual behavior were similar in control rats and rats treated with 40 mg/kg pesticide. Fenvalerate did not exert estrogenic activity in vivo at the tested doses. Data suggest that fenvalerate treatment in this study failed to compromise fertility, possibly due to enhanced reproductive capacity in rodents compared to humans.
Asunto(s)
Insecticidas/efectos adversos , Nitrilos/efectos adversos , Piretrinas/efectos adversos , Espermatozoides/efectos de los fármacos , Animales , Epidídimo/efectos de los fármacos , Femenino , Masculino , Ratas , Ratas Wistar , Recuento de Espermatozoides , Testículo/efectos de los fármacosRESUMEN
Aim: Antisperm antibodies (ASA) in males cause the autoimmune disease 'immune infertility'. The present study intended to detect the presence of ASA and their incidence in men with unexplained infertility, as well as to evaluate the correlation between the presence of ASA and semen parameter alterations. Methods: Blood and sperm assessment were collected to carry out a direct and indirect mixed antiglobulin reaction (MAR) test and semen analysis in infertile and fertile men from the University Hospital of the Faculty of Medicine, Sao Paulo State University, Sao Paulo. Results: In the MAR test, 18.18% of infertile men were positive for ASA. In fertile men, no positivity was found. A significant correlation between the presence of ASA with an increased white blood cell count plus a decreased hypoosmotic swelling test result was observed. Conclusions: The results indicate that ASA are involved in reduced fertility. It is not ASA detection per se that provides conclusive information about the occurrence of damage to fertility. The correlation between infertility and altered seminal parameters reinforce the ASA participation in this pathology. (Reprod Med Biol 2007; 6: 33-38).
RESUMEN
The objective of this work was to evaluate reproductive function in adult male rats exposed to ethanol since puberty. Male Wistar rats, 50 days old, received a liquid diet with 36% of the daily calories derived from ethanol or an isocaloric control diet for 55 days. The ethanol treatment impaired sexual behavior and only 22% of these rats reached ejaculation. The fertility of ethanol-treated animals was significantly reduced, mainly after natural mating. Serum testosterone levels, daily sperm production and sperm count in the epididymis were also significantly diminished after ethanol treatment, associated with an acceleration of the sperm transit time in the cauda epididymidis, decrease in sperm motility and increased percentage of abnormal shaped sperm cells. The results showed that chronic consumption of ethanol beginning at puberty impairs the reproductive function of adult male rats.
Asunto(s)
Etanol/toxicidad , Genitales Masculinos/efectos de los fármacos , Maduración Sexual/efectos de los fármacos , Animales , Depresores del Sistema Nervioso Central/administración & dosificación , Depresores del Sistema Nervioso Central/toxicidad , Eyaculación/efectos de los fármacos , Etanol/administración & dosificación , Femenino , Fertilidad/efectos de los fármacos , Genitales Masculinos/fisiopatología , Masculino , Norepinefrina/farmacología , Fenilefrina/farmacología , Diagnóstico Preimplantación/métodos , Ratas , Ratas Wistar , Conducta Sexual Animal/efectos de los fármacos , Recuento de Espermatozoides/veterinaria , Espermatogénesis/efectos de los fármacos , Espermatozoides/anomalías , Espermatozoides/efectos de los fármacos , Testosterona/sangre , Aumento de Peso/efectos de los fármacos , Pérdida de Peso/efectos de los fármacosRESUMEN
The present study was designed to investigate the effects of a single dose of an estrogen antagonist-clomiphene-during neonatal life, on later neuroendocrine system and reproductive performance. Immediately after birth, male pups received clomiphene citrate (s.c.). At adulthood, although testosterone levels and wet weights of reproductive organs were not altered, the treatment induced an increased number of spermatozoa and a delay in the transit time in the cauda epididymis. Additionally, there was impairment of sexual behavior evidenced by a delay in the latencies to the first mount and first intromission. Treated rats also showed decreased dopaminergic and serotonergic neurotransmissions in the hypothalamus and decreased dopaminergic neurotransmission in the striatum. The decreased dopaminergic activity could be related to the lower sexual motivation observed. These results indicate the necessity of preventing exposure to drugs that may impair sexual differentiation, which can compromise later mating success as well as the capacity to generate descendants.
Asunto(s)
Química Encefálica/efectos de los fármacos , Clomifeno/farmacología , Moduladores de los Receptores de Estrógeno/farmacología , Genitales Masculinos/efectos de los fármacos , Animales , Animales Recién Nacidos , Dopamina/metabolismo , Genitales Masculinos/patología , Masculino , Norepinefrina/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Wistar , Diferenciación Sexual/efectos de los fármacos , Conducta Sexual Animal/efectos de los fármacos , Testosterona/sangreRESUMEN
The present study was designed to examine some short- and long-term effects of maternal restraint stress--during the period of sexual brain differentiation--on reproductive and endocrine systems, sexual behavior, and brain neurotransmitters in male rat descendants. Pregnant rats were exposed to restraint stress for 1 h/day from gestational days (GDs) 18 to 22. Prenatal stress did not influence the wet weight of sexual organs and the quantity of germ cells in adult male pups; however, these animals showed reduced testosterone levels, delayed latency to the first mount and first intromission, and also decreased number of ejaculations. Additionally, there was an increase in the dopamine and serotonin levels in the striatum. Our results indicate that prenatal stress had a long-term effect on neurotransmitter levels and sexual behavior. In this sense, reproductive problems caused by injuries during the fetal period can compromise the later success of mating as well as the capacity to generate descendants.
Asunto(s)
Química Encefálica/fisiología , Efectos Tardíos de la Exposición Prenatal , Conducta Sexual Animal/fisiología , Estrés Fisiológico/fisiopatología , Testosterona/sangre , Glándulas Suprarrenales/crecimiento & desarrollo , Factores de Edad , Animales , Conducta Animal , Monoaminas Biogénicas/metabolismo , Peso Corporal/fisiología , Femenino , Inmovilización , Masculino , Actividad Motora/fisiología , Tamaño de los Órganos/fisiología , Embarazo , Ratas , Ratas Wistar , Caracteres Sexuales , Diferenciación Sexual , Estrés Fisiológico/metabolismoRESUMEN
The effects of maternal exposure to aromatase inhibitor during the perinatal period of sexual brain differentiation were studied. The fertility was assessed in adult, male rat offspring of aromatase inhibitor-treated dams. The following results were obtained: (1) Sexual maturation, body weight, and wet weights of testis, pituitary, seminal vesicle, ventral prostate, and levatori ani muscle were unchanged at adult life. (2) Fifty percent of the animals were able to mate with normal females, which became pregnant but exhibited an increased number of preimplantation loss. (3) There was a decrease in the number of spermatozoa found in the testes and in the daily sperm production. (4) Of those, 25% of the male rats treated with aromatase inhibitor did not present male sexual behavior, showing female behavior when pretreated with estrogen. These results indicate that perinatal exposure to aromatase inhibitor during the critical period of male brain sexual differentiation has a long-term effect on the reproductive physiology and behavior of male rats.
Asunto(s)
Inhibidores de la Aromatasa , Inhibidores Enzimáticos/farmacología , Efectos Tardíos de la Exposición Prenatal , Conducta Sexual Animal/efectos de los fármacos , Animales , Aromatasa/biosíntesis , Femenino , Fertilidad/efectos de los fármacos , Fertilidad/fisiología , Letrozol , Masculino , Nitrilos/farmacología , Embarazo , Ratas , Ratas Wistar , Reproducción/efectos de los fármacos , Reproducción/fisiología , Diferenciación Sexual/efectos de los fármacos , Diferenciación Sexual/fisiología , Conducta Sexual Animal/fisiología , Espermatozoides/efectos de los fármacos , Espermatozoides/enzimología , Triazoles/farmacologíaRESUMEN
Functional studies have shown that orchidectomy increases the effects of phenylephrine on rat portal veins, but that it is completely prevented in the presence of both ETA and ETB receptor antagonists. Although it suggests the involvement of endothelin-1 (ET-1), the local production of this vasoactive peptide has not been directly quantified in portal veins. Therefore, the aim of the present study was to verify if orchidectomy increases the local expression of ET-1 as well as ETA and ETB receptors in the rat portal vein. Indeed, the genic expression of ET-1, ETA and ETB receptors in rat portal veins taken from control (CONT), orchidectomized (ORX) and ORX plus testosterone-replacement therapy (ORX + T) animals were determined by Real Time RT-PCR. The results showed that orchidectomy induced a significant increment in genic expression of ET-1 and ETB receptors in the rat portal veins, which was completely reversed by testosterone replacement treatment. In conclusion, the results suggest that orchidectomy increases the production of ET-1 in the rat portal vein and that, at least partially, it may be related to the previously reported elevation of responses to phenylephrine.
Asunto(s)
Endotelina-1/sangre , Orquiectomía , Vena Porta/fisiología , Receptor de Endotelina B/sangre , Animales , Atrofia , Endotelina-1/genética , Expresión Génica , Masculino , Próstata/patología , Ratas , Receptor de Endotelina A/genética , Receptor de Endotelina B/genética , Vesículas Seminales/patología , Testosterona/sangre , Testosterona/farmacologíaRESUMEN
The objective of this study was to investigate whether prenatal exposure to testosterone (T) could change the body weight (BW), anogenital distance (AGD), anogenital distance index (AGDI), puberty onset, social behavior, fertility, sexual behavior, sexual preference, and T level of male rats in adulthood. To test this hypothesis, pregnant rats received either 1 mg/animal of T propionate diluted in 0.1 ml peanut oil or 0.1 ml peanut oil, as control, on the 17th, 18th and 19th gestational days. No alterations in BW, AGD, AGDI, fertility, and sexual behavior were observed (p > 0.05). Delayed onset of puberty (p < 0.0001), increased aggressive behavior (p > 0.05), altered pattern of sexual preference (p < 0.05), and reduced T plasma level (p < 0.05) were observed for adult male rats exposed prenatally to T. In conclusion, the results showed that prenatal exposure to T was able to alter important aspects of sexual and social behavior although these animals were efficient at producing descendants. In this sense more studies should be carried to evaluated the real impact of this hormonal alteration on critical period of sexual differentiation on humans, because pregnant women exposed to hyperandrogenemia and then potentially exposing their unborn children to elevated androgen levels in the uterus can undergo alteration of normal levels of T during the sexual differentiation period, and, as a consequence, affect the reproductive and behavior patterns of their children in adulthood.
Asunto(s)
Agresión/efectos de los fármacos , Efectos Tardíos de la Exposición Prenatal/fisiopatología , Efectos Tardíos de la Exposición Prenatal/psicología , Conducta Sexual Animal/efectos de los fármacos , Maduración Sexual/efectos de los fármacos , Propionato de Testosterona/administración & dosificación , Animales , Femenino , Edad Gestacional , Masculino , Modelos Animales , Embarazo , Ratas , Ratas Wistar , Diferenciación Sexual/efectos de los fármacos , Conducta Social , Testosterona/sangreRESUMEN
BACKGROUND: The aim of this study was to evaluate the changes in testicular function of rats due to cigarette smoke exposure and the possible mechanism by which zinc protects against these alterations. METHODS: Male Wistar rats (60 days old) were randomly divided into 3 groups: control (G1, n = 10); exposed to cigarette smoke (G2, n = 10; 20 cigarettes/day/9 weeks) and exposed to cigarette smoke and supplemented with zinc (G3, n = 8; 20 cigarettes/day/9 weeks; 20 mg/kg zinc chloride daily for 9 weeks, by gavage). After the treatment period, the animals were euthanized, and materials were collected for analyses. RESULTS: G2 rats showed a reduction in body mass; impaired sperm concentration, motility, morphology and vitality; and increased malonaldehyde and thiol group levels and superoxide dismutase activity as compared to G1. Zinc prevented the reduction of sperm concentration and the excessive increase of lipid peroxidation and induced an increase in plasma testosterone levels, wet weight of testis and thiol group concentration. CONCLUSIONS: Exposure to cigarette smoke led to harmful effects on testicular function at least partially due to the exacerbation of oxidative stress. Supplementary zinc had an important modulator/protector effect on certain parameters. The mechanism of zinc protection can be through an increase of SH concentration. Thus, zinc supplementation may be a promising addition to conventional treatments for male infertility related to smoking.
Asunto(s)
Cloruros/farmacología , Suplementos Dietéticos , Sustancias Protectoras/farmacología , Humo/efectos adversos , Testículo/efectos de los fármacos , Contaminación por Humo de Tabaco/efectos adversos , Compuestos de Zinc/farmacología , Animales , Peso Corporal/efectos de los fármacos , Cloruros/administración & dosificación , Citoprotección , Esquema de Medicación , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Compuestos de Sulfhidrilo/metabolismo , Superóxido Dismutasa/metabolismo , Testículo/metabolismo , Testículo/patología , Testículo/fisiopatología , Testosterona/sangre , Factores de Tiempo , Compuestos de Zinc/administración & dosificaciónRESUMEN
This study investigated the effects of perinatal treatment with flutamide on male sexual behavior, semen parameters, and fertility in adult male rats. Pregnant rats received 15 mg/kg of flutamide or peanut oil, s.c., at days 19 and 22 of pregnancy and for the first five postnatal days. Treated male offspring showed increases in latency to copulatory behavior, number of mounts without penis intromission, number of intromissions until ejaculation, latency to ejaculation, and reduced number of ejaculations. Flutamide treated rats presented reductions in weight of testes and prostate, percentage of normal spermatozoa, spermatozoa concentration, testicular sperm production, and testosterone level. Normal females mated with treated males presented more pre-implantation losses, reduced implantation rates, and consequently reduced offspring size. The results indicated that perinatal flutamide treatment damaged organizational processes of sexual differentiation, which led to inefficiency in copulatory behavior and reductions in sperm quality and count, resulting in low capacity for producing descendants.
Asunto(s)
Antagonistas de Andrógenos/toxicidad , Copulación/efectos de los fármacos , Fertilidad/efectos de los fármacos , Flutamida/toxicidad , Exposición Materna/efectos adversos , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Espermatozoides/efectos de los fármacos , Animales , Animales Recién Nacidos , Copulación/fisiología , Femenino , Fertilidad/fisiología , Genitales Masculinos/efectos de los fármacos , Genitales Masculinos/patología , Inyecciones Subcutáneas , Tamaño de la Camada/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Embarazo , Efectos Tardíos de la Exposición Prenatal/sangre , Efectos Tardíos de la Exposición Prenatal/patología , Ratas , Ratas Wistar , Maduración Sexual/efectos de los fármacos , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Espermatozoides/fisiología , Testosterona/sangreRESUMEN
Hyperglycemic and hypoinsulinemic states caused by diabetes mellitus are usually related to some type of sexual dysfunction, resulting in infertility in humans and experimental models, mostly due to their effects on ejaculatory function. This study aimed to evaluate the possible role of testosterone in the restoration of normal ejaculatory function in diabetic rats. Male Wistar rats were randomly allocated into 3 experimental groups: control, diabetic (streptozotocin), and diabetic with testosterone supplementation (streptozotocin plus testosterone). The following parameters were assessed at the end of the experiment: body weight, circulating testosterone levels, number of spermatozoa ejaculated in the uterus through natural mating, and weight and in vitro isometric contractions of the vas deferens. Diabetic rats showed reduced plasma testosterone levels and ejaculatory dysfunction as observed by a lack in the spermatozoa ejaculated into the uterus of receptive females. In these diabetic rats, no difference was observed in the sensitivity of the vas deferens to norepinephrine, with or without the presence of the cocktail (cocaine plus propranolol). In spite of this, an increased sensitivity to methoxamine through the α1-adrenoceptor was observed. Testosterone supplementation did not restore these parameters to control values.We conclude that, in this experimental model, the lack of testosterone was not directly related to the diabetes-induced ejaculatory dysfunction.
Asunto(s)
Diabetes Mellitus Experimental/complicaciones , Eyaculación/efectos de los fármacos , Disfunciones Sexuales Fisiológicas/tratamiento farmacológico , Testosterona/farmacología , Andrógenos/sangre , Andrógenos/farmacología , Animales , Peso Corporal , Cocaína/farmacología , Femenino , Masculino , Norepinefrina/metabolismo , Propranolol/farmacología , Distribución Aleatoria , Ratas , Ratas Wistar , Disfunciones Sexuales Fisiológicas/etiología , Espermatozoides/efectos de los fármacos , Espermatozoides/metabolismo , Estreptozocina , Testosterona/sangreRESUMEN
Diabetic neuropathy can affect the male reproductive system. The aim of this study was therefore to evaluate whether antioxidant (vitamins C and/or E) treatment could attenuate reproductive dysfunctions in hyperglycemic adult male rats. The animals were randomly assigned to one of four experimental groups: hyperglycemic control (Hy), hyperglycemic + 150 mg/day vitamin C (HyC), hyperglycemic + 100 mg/day vitamin E (HyE) or hyperglycemic + vitamins C and E (HyCE). The normoglycemic group (n = 10) received only the vehicles. The testosterone level and noradrenergic response of the vas deferens were analyzed. Both vitamins significantly decreased the TBARS (thiobarbituric acid reactive species) level in the hyperglycemic groups. There was a significant reduction in the testosterone level in the Hy and HyE groups when compared to the normoglycemic group. However, the testosterone levels were partially recovered in the HyC and HyCE groups. In addition, an increased sensitivity of the α-1 adrenoceptor in the vas deferens of the hyperglycemic control group was observed. Treatment with vitamins partially restored (vitamin E or in combination with vitamin C) or totally (vitamin C alone) this dysfunction. Moreover, the maximum response values to norepinephrine were similar among all groups. Thus, we concluded that vitamin C is more efficient than vitamin E in attenuating the effects of hyperglycemia on the male reproductive system of adult rats.
Asunto(s)
Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Hiperglucemia/complicaciones , Vitamina E/farmacología , Andrógenos/metabolismo , Animales , Neuropatías Diabéticas/complicaciones , Masculino , Ratas , Ratas Wistar , Receptores Adrenérgicos alfa 1/metabolismo , Testosterona/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Conducto Deferente/efectos de los fármacos , Conducto Deferente/metabolismoRESUMEN
AIMS: To investigate the response to norepinephrine of vas deferens isolated from intact and castrated rats submitted to swimming and/or treated with nandrolone decanoate. MAIN METHODS: Intact and castrated male rats were submitted to swimming for 15 days, 1 session per day, 5 days/week and were either treated or not with 7.5 mg/kg of nandrolone decanoate on days 1, 5, 9, and 13 after the beginning of training. Plasma androgen concentration was measured by radioimmunoassay. Vas deferens was isolated and set up for analysis of its contractile capacity in response to norepinephrine. KEY FINDINGS: In intact rats, nandrolone, training, and training plus nandrolone did not change body mass or vas deferens weight. In castrated rats, the vas deferens wet weight was decreased in both untrained and trained groups. In castrated rats, nandrolone prevented vas deferens atrophy. In intact animals, nandrolone decreased (P<0.05) the androgen level in untrained group, while in castrated rats this treatment partially restored the androgen level. An increased sensitivity (P<0.05) to norepinephrine was observed in vas deferens isolated from intact trained rats, treated or not with nandrolone decanoate, while nandrolone did not alter norepinephrine response in organs from untrained animals. In untrained castrated rats, nandrolone fully restored the sensitivity to norepinephrine in untrained rats, while in trained castrated rats the anabolic steroid only partially restored this response. SIGNIFICANCE: The present results indicate that training can increase norepinephrine response of vas deferens in intact rats, while nandrolone decanoate can partially restore the responsiveness to norepinephrine in castrated rats.
Asunto(s)
Anabolizantes/farmacología , Nandrolona/análogos & derivados , Norepinefrina/farmacología , Natación , Conducto Deferente/efectos de los fármacos , Vasoconstrictores/farmacología , Animales , Masculino , Nandrolona/farmacología , Nandrolona Decanoato , Tamaño de los Órganos , Ratas , Ratas WistarRESUMEN
The aim of this study was to investigate long-term effects of prenatal betamethasone exposure on sexual partner preference, testosterone level, and sexual behavior. Pregnant rats received 0.1 mg/kg of betamethasone or saline on the 12th, 13th, 18th, and 19th days of pregnancy. Parameters in male offspring were evaluated at 90 days of age. Male rats from the betamethasone group did not show any difference in sexual partner preference as expressed by the total number of visits to the female or male zone. However, these males spent significantly less total time and shorter duration per visit in the female zone than their controls. Therefore, prenatal exposure to betamethasone led to a significantly lower sexual female partner preference score compared to the control group. These animals also presented diminished testosterone levels in adulthood. Prenatal exposure to betamethasone induced a delay in the latency to first ejaculation, as well as a decrease in the numbers of postejaculatory intromissions, total intromissions and total ejaculations. Although 80% of the betamethasone-treated animals exhibited male sexual behavior, when they were castrated and pretreated with estrogen, 50% of them showed lordosis and accepted mounts of another sexually experienced male. These results suggest that the prenatal treatment with betamethasone, by increasing maternal corticosteroid level, may have diminished testosterone peak in male pups, a peak crucial to brain sexual differentiation. As a consequence, the prenatal betamethasone treatment reduced the testosterone level in adulthood and altered partner preference and sexual behavior.
Asunto(s)
Antiinflamatorios/farmacología , Betametasona/farmacología , Efectos Tardíos de la Exposición Prenatal , Conducta Sexual Animal/efectos de los fármacos , Canal Anal/efectos de los fármacos , Canal Anal/crecimiento & desarrollo , Animales , Peso Corporal/efectos de los fármacos , Copulación/efectos de los fármacos , Eyaculación/efectos de los fármacos , Femenino , Genitales/efectos de los fármacos , Genitales/crecimiento & desarrollo , Masculino , Orquiectomía , Embarazo , Ratas , Ratas Wistar , Diferenciación Sexual/efectos de los fármacos , Testosterona/sangreRESUMEN
The present study evaluated the effects of histamine 10(-2) M on longitudinal preparations of rat portal vein. It was observed that histamine 10(-2) M induced relaxation of rat portal vein preparations pre-contracted with phenylephrine 10(-4) M. On the other hand, no pharmacological effects were observed in preparations not pre-contracted. The observed histamine-induced relaxing effect was absent in preparations pre-contracted with KCl (120 mM) or in the presence of depolarizing nutritive solution. However, the histamine-induced relaxation was still present in the endothelium-removed preparations. The histamine-induced relaxation also was not prevented by astemizole (10(-6) M, 10(-5) M and 10(-4) M), cimetidine (10(-5) M, 10(-4) M and 10(-3) M) or thioperamide (10(-6) M, 10(-5) M and 10(-4) M), selective antagonists H(1), H(2) and H(3), respectively. The presence of L-NAME 10(-4) M or L-NAME 10(-4) M plus indomethacin 10(-5) M also did not prevent the histamine-induced relaxation observed in rat portal vein. Thus, the histamine-induced relaxation observed in rat portal vein appears to involve a non-endothelial hyperpolarizing mechanism independent of H(1), H(2) and H(3) receptors.